openPR Logo
Press release

Hidradenitis Treatment Market Size in the 7MM is expected to grow a significant CAGR by 2032, estimates DelveInsight | Sanofi, Novatis Pharmaceuticals, ACELYRIN Inc., Avalo Therapeutics Inc., Incyte Corporation, Moonlake Immunotherapeutics AG

03-10-2025 10:43 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Hidradenitis Market

Hidradenitis Market

DelveInsight's "Hidradenitis Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hidradenitis, historical and forecasted epidemiology as well as the Hidradenitis market trends in the United States.

Discover which therapies are expected to grab the Hidradenitis Market Share @ Hidradenitis Market Outlook- https://www.delveinsight.com/sample-request/hidradenitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Hidradenitis Market Report
• In March 2025:- UCB Biopharma SRL announced a study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS).
• In March 2025:- AbbVie conducted a Phase 3 Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy.
• In March 2025;- Insmed Incorporated announced a study is evaluate the effect of brensocatib compared with placebo.
• The increase in Hidradenitis Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Hidradenitis Market is anticipated to witness growth at a considerable CAGR.
• The leading Hidradenitis Companies such as Sanofi, Novatis Pharmaceuticals, ACELYRIN Inc., Avalo Therapeutics Inc., Incyte Corporation, Moonlake Immunotherapeutics AG, and others.
• Promising Hidradenitis Pipeline Therapies such as Amlitelimab, Anifrolumab, Izokibep, AVTX-009, Ruxolitinib cream, Sonelokimab and others

Discover which therapies are expected to grab the Hidradenitis Market Share @ Hidradenitis Market Outlook- https://www.delveinsight.com/sample-request/hidradenitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Hidradenitis Epidemiology Insights
The epidemiology section of Hidradenitis offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

Download the report to understand which factors are driving Hidradenitis Epidemiology trends @ Hidradenitis Prevalence- https://www.delveinsight.com/sample-request/hidradenitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Hidradenitis Drugs Market
The Hidradenitis Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Hidradenitis signaling in Hidradenitis are likely to uncover new therapeutic targets and further expand treatment options for patients.

Hidradenitis Treatment Market Landscape
The Hidradenitis treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Hidradenitis has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To learn more about Hidradenitis treatment guidelines, visit @ Hidradenitis Treatment Market Landscape- https://www.delveinsight.com/sample-request/hidradenitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Hidradenitis Market Outlook
The report's outlook on the Hidradenitis market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Hidradenitis therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Hidradenitis drug and late-stage pipeline therapy.

Hidradenitis Drugs Uptake
The drug chapter of the Hidradenitis report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Hidradenitis.

Major Hidradenitis Companies
Sanofi, Novatis Pharmaceuticals, ACELYRIN Inc., Avalo Therapeutics Inc., Incyte Corporation, Moonlake Immunotherapeutics AG, and others

Learn more about the FDA-approved drugs for Hidradenitis @ Drugs for Hidradenitis Treatment- https://www.delveinsight.com/sample-request/hidradenitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Hidradenitis Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Hidradenitis Companies- Sanofi, Novatis Pharmaceuticals, ACELYRIN Inc., Avalo Therapeutics Inc., Incyte Corporation, Moonlake Immunotherapeutics AG, and others
• Hidradenitis Therapies- Amlitelimab, Anifrolumab, Izokibep, AVTX-009, Ruxolitinib cream, Sonelokimab and others
• Hidradenitis Market Dynamics: Hidradenitis Market Drivers and Barriers
• Hidradenitis Market Access and Reimbursement, Unmet Needs and Future Perspectives

Discover more about Hidradenitis Drugs in development @ Hidradenitis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/hidradenitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Hidradenitis Market Report Introduction
3. Hidradenitis Market Overview at a Glance
4. Executive Summary of Hidradenitis
5. Key Events
6. Hidradenitis Epidemiology and Market Methodology
7. Hidradenitis Disease Background and Overview
8. Hidradenitis Epidemiology and Patient Population
9. Hidradenitis Patient Journey
10. Hidradenitis Marketed Therapies
11. Hidradenitis Emerging Therapies
12. Hidradenitis: Market Analysis
13. Hidradenitis KOL Views
14. Hidradenitis SWOT Analysis
15. Hidradenitis Unmet Needs
16. Hidradenitis Market Access
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight

List of Top Selling Market Research Reports in 2025

Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/underactive-bladder-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Surgical robotic system market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical sealant market - https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Ventral hernia market- https://www.delveinsight.com/report-store/hernia-repair-devices-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Trichotillomania market- https://www.delveinsight.com/sample-request/trichotillomania-ttm-market
Medical marijuana market- https://www.delveinsight.com/blog/medical-marijuana-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hidradenitis Treatment Market Size in the 7MM is expected to grow a significant CAGR by 2032, estimates DelveInsight | Sanofi, Novatis Pharmaceuticals, ACELYRIN Inc., Avalo Therapeutics Inc., Incyte Corporation, Moonlake Immunotherapeutics AG here

News-ID: 3906994 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Hidradenitis

Drugs for Hidradenitis Suppurativa Market Size Report 2025
Global Info Research announces the release of the report "Global Drugs for Hidradenitis Suppurativa Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides a detailed overview of the Drugs for Hidradenitis Suppurativa market scenario, including a thorough analysis of the Drugs for Hidradenitis Suppurativa market size, sales quantity, revenue, gross margin and market share.The Drugs for Hidradenitis Suppurativa report provides an in-depth analysis of the
Drugs for Hidradenitis Suppurativa Latest Market Analysis Report 2025
"Global Drugs for Hidradenitis Suppurativa Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031" is published by Global Info Research. It covers the key influencing factors of the Drugs for Hidradenitis Suppurativa market, including Drugs for Hidradenitis Suppurativa market share, price analysis, competitive landscape, market dynamics, consumer behavior, and technological impact, etc.At the same time, comprehensive data analysis is conducted by national and regional, corporate competition rankings, product
Hidradenitis Suppurativa Market Forecast Report 2024-2033 | Analysis and Insight …
The hidradenitis suppurativa market size has grown strongly in recent years. It will grow from $1.06 billion in 2023 to $1.15 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased diagnosis awareness, limited treatment options, advancements in dermatology, rising disease prevalence, patient advocacy initiatives. The hidradenitis suppurativa market size is expected to see strong growth
Global Hidradenitis Suppurativa Therapeutics Market forecast 2022 to 2029
Global Industrial aspects of Hidradenitis Suppurativa Therapeutics Sales Market 2023-2029: The global Hidradenitis Suppurativa Therapeutics Market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Hidradenitis Suppurativa Therapeutics is estimated to increase from $ million in
Hidradenitis Suppurativa Treatment Market Structure to Broaden between 2020 and …
Hidradenitis suppurativa treatment also called as acne inversa, is a long term dermatological disease which occur due to swollen lumps. They are painful and break open, and release fluid or pus. The most affected areas of the body are underarms, under the breasts, and groin. Additionally, disease generally occurs due to secondary infection, obstruction of hair follicles, and inflammation of certain sweat glands which are boosting the market growth of
Hidradenitis Suppurativa Therapeutics Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Hidradenitis Suppurativa Therapeutics market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Hidradenitis Suppurativa Therapeuticsmarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Hidradenitis Suppurativa Therapeuticsmarket, market definition, overview, industry opportunities